Topical preparations for rosacea (Formulary)
Refer to guidance on Management of rosacea and Anti-infective skin preparations for metronidazole (Rozex®) cream 0·75% used in rosacea.
Important: Therapy notes
MHRA advice: Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin (June 2017) (www.gov.uk).
MHRA advice: Brimonidine gel (Mirvaso): risk of exacerbation of rosacea (November 2016) (www.gov.uk).